Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism NTRK modulators(Neurotrophic tyrosine kinase receptor modulators) |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | United States | 01 Oct 2016 | |
Amyotrophic Lateral Sclerosis | Preclinical | United States | 01 Oct 2016 |